High‐frequency (20 MHz) high‐intensity focused ultrasound: New Treatment of actinic keratosis, basal cell carcinoma, and Kaposi sarcoma. An open‐label exploratory study

MLA

Torsten Bove, et al. “High‐frequency (20 MHz) High‐intensity Focused Ultrasound: New Treatment of Actinic Keratosis, Basal Cell Carcinoma, and Kaposi Sarcoma. An Open‐label Exploratory Study.” Skin Research and Technology, vol. 26, June 2020, pp. 824–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d37d74060d88d2c9a0a35e3e536c8669&authtype=sso&custid=ns315887.

APA

Torsten Bove, Jørgen Serup, Alexander Jessen, Tomasz Zawada, & Mattia Poli. (2020). High‐frequency (20 MHz) high‐intensity focused ultrasound: New Treatment of actinic keratosis, basal cell carcinoma, and Kaposi sarcoma. An open‐label exploratory study. Skin Research and Technology, 26, 824–831.

Chicago

Torsten Bove, Jørgen Serup, Alexander Jessen, Tomasz Zawada, and Mattia Poli. 2020. “High‐frequency (20 MHz) High‐intensity Focused Ultrasound: New Treatment of Actinic Keratosis, Basal Cell Carcinoma, and Kaposi Sarcoma. An Open‐label Exploratory Study.” Skin Research and Technology 26 (June): 824–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d37d74060d88d2c9a0a35e3e536c8669&authtype=sso&custid=ns315887.